PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of gutGutVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
 
Gut. 2001 September; 49(3): 431–435.
PMCID: PMC1728437

Outcome of liver disease in children with Alagille syndrome: a study of 163 patients

Abstract

BACKGROUND AND AIMS—Various opinions have been expressed as to the long term prognosis of liver disease associated with Alagille syndrome (AGS).
PATIENTS AND METHODS—We reviewed the outcome of 163 children with AGS and liver involvement, investigated from 1960 to 2000, the end point of the study (median age 10 years (range 2 months to 44 years)) being death, liver transplantation, or the last visit.
RESULTS—At the study end point, of the 132 patients who presented with neonatal cholestatic jaundice, 102 remained jaundiced, 112 had poorly controlled pruritus, and 40 had xanthomas; cirrhosis was found in 35/76 livers, varices in 25/71 patients, and liver transplantation had been carried out in 44 patients (33%). Forty eight patients died, 17 related to complications of liver disease. Of 31 patients who did not present with neonatal cholestatic jaundice, five were jaundiced at the study end point, 17 had well controlled pruritus, and none had xanthomas; cirrhosis was found in 6/18 patients, varices in 4/11, and none underwent liver transplantation. Nine patients died, two of liver disease. In the whole series, actuarial survival rates with native liver were 51% and 38% at 10 and 20 years, respectively, and overall survival rates were 68% and 62%, respectively. Neonatal cholestatic jaundice was associated with poorer survival with native liver (p=0.0004).
CONCLUSIONS—The prognosis of liver disease in AGS is worse in children who present with neonatal cholestatic jaundice. However, severe liver complications are possible even after late onset of liver disease, demanding follow up throughout life.


Keywords: Alagille syndrome; cholestasis; end stage liver disease; liver transplantation

Figure 1
Survival with native liver in 163 patients with Alagille syndrome and chronic liver disease. 1, 132 patients with neonatal cholestatic jaundice; 2, 31 patients with late onset cholestasis (p=0.0004).

Articles from Gut are provided here courtesy of BMJ Publishing Group